Each year, a summary report is generated to document the Annual WRI Meeting in order to best provide direction for WRI's ongoing work to advance the research for HIV+ women. Building on the growing momentum of recent WRI accomplishments, the 2006 meeting focused on two key concepts: first, identifying the most critical constraints to accelerating progress in research and second, focusing our efforts only on those specific constraints within our direct sphere of influence. This approach helped the WRI to zero in on a few key initiatives for the coming year. These initiatives can be broadly described as addressing two basic questions:
- What things do we not know that, if known, could significantly impact the course of the epidemic?
- What things do we know which, if broadly disseminated, could significantly impact the course of the epidemic?
To accomplish this, the WRI identified initiatives in three areas:
- Research “policies, practices, and priorities”
- Clinical Trial Network Accountability
- Community engagement and leadership development
Attending the meeting were members of the WRI (including representatives from clinical care, HIV research, academia, community-based organizations, government, the pharmaceutical industry and HIV-positive women), guest speakers and invited experts. A list of the 2006 WRI Meeting members, speakers and participants can be found below.
2006 WRI Meeting Participants
Richard Averitt
The Well Project
Julie Barroso
Duke University School of Nursing
Dawn Averitt Bridge
The Well Project
Gina Brown, MD
Maternal-Fetal Specialist
New York city Department of Health and Mental Hygiene
Rebecca Clark, MD
LSU HSC
Susan Ellen Cohn, MD, MPH
Associate Professor of Medicine
University of Rochester
Elizabeth Connick, MD
Associate Professor of Medicine
University of Colorado at Denver and Health Sciences Center
Robert W. Coombs, MD, PhD, FRCPC
Professor, Laboratory Medicine & Medicine
University of Washington
Terri Creagh, PhD
Director of Research
Clinical and Epidemiologic Research
Kristy Grimm
Associate Director, Virology Medical Strategy
Bristol-Myers Squibb
Jane Hitti, MD
Associate Director
University of Washington Medical Center, Dept. Ob/Gyn
Sally L. Hodder, MD
University of Medicine & Dentistry of New Jersey
Katherine Hollinger, DVM, MPH
FDA/Office of Women’s Health
Rowena Johnston, PhD
Director, Research
AmfAR – The Foundation for AIDS Research
Ben Kozub
Boehringer Ingelheim
Sharon Lee
Director
Family Health Care
Meagan Lyon, MPH
Senior Research Assistant
Forum for Collaborative HIV Research
Cathy Olufs
Education Director
The Center for Health Justice (formerly CorrectHELP)
Andrew Pavia, MD
Professor and Chief, Division of Pediatric
Infectious Disease
University of Utah
Martell Randolph
Community Educator
AIDS Research Alliance
Claire Rappaport
Community Liaison
International Network for Strategic Initiative in Global HIV Trials
(INSIGHT)
Patricia Reichelderfer
NIH/NICHD
Wendy Rhein
Executive Director
The Well Project
Alex Rinehart
Associate Medical Director
Tibotec Therapeutics
Yolanda Rodriguez-Escobar
Executive Director
Mujeres Unides Corba el SIDA
Ellie Schoenbaum, MD
Director of AIDS Research Program
Montefiore Medical Center
Stephen P. Storfer, MD
Senior Associate Director, Virology
Boehringer Ingelheim Pharmaceuticals, Inc.
Kimberly Struble, PharmD
Medical Team Leader
Food and Drug Administration, Division of Antiviral Products
Melanie Thompson, MD
Principal Investigator
AIDS Research Consortium of Atlanta
Fulvia Veronese, PhD
Chair, HIV/AIDS Etiology and Pathogenesis
Coordinating Committee
NIH, Office of AIDS Research
Ron Wilder
President
Aligned Action, Inc.
